Search clinical trials for: SAE serious adverse event

Total 5817 results

FHI 360
University of Cape Town; City University of New York, School of Public Health

Completed

Comparison of Two Intrauterine Devices (IUDs) Among Cape Town HIV-positive Women

HIV

South Africa
FHI 360
United States Agency for International Development (USAID); University of Witwatersrand...

Completed

Assessing Preference for 3 Female Condoms: A Comparative Evaluation of the PATH Woman's Condom, FC2 and the Reddy 6

Contraception

South Africa
Eli Sprecher, MD
OBCTCD24 Ltd

Active, not recruiting

A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection

COVID-19 Disease

Israel
The HIV Netherlands Australia Thailand Research...
National Health Security Office, Thailand; Ministry of Education, Thailand

Completed

Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy

Thailand
GlaxoSmithKline

Completed

The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Infections, Papillomavirus

Russian Federation, Singapore, Australia, Portugal
GlaxoSmithKline

Completed

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Infections, Papillomavirus

United States, Canada
GlaxoSmithKline

Completed

Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study

Infections, Papillomavirus

Brazil
FHI 360

Completed

Long-Acting Reversible Contraception (LARC)

Contraception

United States
FHI 360
Bill and Melinda Gates Foundation

Completed

Safety,Effectiveness and Acceptability of Sino-implant II in DR

Contraception

Dominican Republic
HIV Prevention Trials Network

Completed

HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)

HIV

United States
FHI 360
Elizabeth Glaser Pediatric AIDS Foundation; Mbarara University of Science and...

Completed

Male Engagement in PMTCT Services

HIV

Uganda
FHI 360
Eastern Virginia Medical School

Completed

PK of Depo SubQ Injected in the Upper Arm

Contraception

United States
FHI 360
United States Agency for International Development (USAID); PATH

Completed

Acceptability of Depo-subQ in Uniject

Contraception

Senegal, Uganda
FHI 360
United States Agency for International Development (USAID)

Completed

A Prospective Observational Study of the Clinical Performance of Femplant in Pakistan

Contraception

Pakistan
FHI 360
United States Agency for International Development (USAID)

Completed

A Prospective Observational Study of the Performance of Zarin in Kenya

Contraceptive Usage

Kenya
FHI 360
Bill and Melinda Gates Foundation; Marie Stopes International

Completed

A Prospective Observational Study of the Clinical Performance of Zarin in Madagascar

Long-term and Permanent Contraceptive Methods

Madagascar
FHI 360
United States Agency for International Development (USAID)

Completed

Family Planning Through Dairy Cooperatives

The Study Goal is to Assess the Introduction of Sustainable Family Planning/Reproductive Health Information and Services Through | Land O' Lakes-supported Dairy Cooperatives

Kenya
FHI 360
La Asociación Pro Bienestar de la Familia de Guatemala (APROFAM)

Completed

Continuous Use of COCs

Pregnancy Prevention

Dominican Republic, Nicaragua
FHI 360
Muhimbili University of Health and Allied Sciences

Completed

Integration of Family Planning and HIV Services in Tanzania

HIV Infections | HIV Infection

Tanzania
FHI 360
Lagos State University; University of Port Harcourt Teaching Hospital

Terminated

Cellulose Sulfate (CS) Gel and HIV in Nigeria

HIV Infections | Gonorrhea | Chlamydia Infections

Nigeria
FHI 360

Completed

Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

HIV Infections

Cameroon, Ghana, Nigeria
FHI 360

Terminated

Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

HIV Infections

Malawi
FHI 360
University of North Carolina; Ministry of Health, Madagascar; National Reference...

Completed

Madagascar Female Condom Study

Sexually Transmitted Diseases

Madagascar
Sohag University

Not yet recruiting

Predictive Value of Serum Uric Acid to HDL Cholesterol Ratio for Diabetic Kidney Injury in Type 2 Diabetes

Diabetic Kidney Injury
Zhujiang Hospital

Not yet recruiting

Effectiveness of Atorvastatin in Preventing Cerebrovascular Events After Flow Diverter Implantation

Efficacy Endpoint: no New Cerebrovascular Adverse Events Within 1 Year | Safety Endpoint: no New Moderate or Serious Adverse Events Within 1 Year | All-cause Mortality Events (Within 1 Year) | Incident Ischemic Stroke Events (Within 1 Year) | New Hemorrhagic Stroke Events (Within 1 Year) | New... and other conditions
Eli Lilly and Company

Recruiting

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Elevated Lp(a) | Atherosclerotic Cardiovascular Disease (ASCVD)

Taiwan, United States, Spain, Argentina, China, Italy, Australia, France, Canada, Japan, Belgium, Denmark, Germany, Hungary, Israel, Austria, Korea, Republic of, Brazil, Mexico, Netherlands, Romania, United Kingdom, Greece, Czechia, India, Slovak... and more
Jasper Gerritsen
Massachusetts General Hospital; Universitaire Ziekenhuizen KU Leuven; University... and other collaborators

Recruiting

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) (RECSUR)

Glioblastoma | Glioblastoma Multiforme | Recurrent Glioblastoma | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme, Adult | Glioblastoma Multiforme of Brain | Astrocytoma of Brain | Astrocytoma, Malignant

United States, Germany, Netherlands, Switzerland, Belgium
Centre Hospitalier Régional Metz-Thionville
Georgia Institute of Technology

Recruiting

Prediction Of Serious Adverse Event in Emergency Department With dysKAlemia, Retrospective Study (PODKA-R)

Emergencies

France
The Immunobiological Technology Institute (Bio-Manguinhos)...
Oswaldo Cruz Foundation

Recruiting

Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil

Guillain-Barre Syndrome | Transverse Myelitis | Acute Disseminated Encephalomyelitis | Vaccine-induced Thrombotic Thrombocytopenia Syndrome

Brazil
Medical University of Gdansk

Recruiting

Assessment of Immune Response After Vaccination Against COVID-19 in Patients Treated With Renal Replacement Therapy (COViNEPH-1)

Covid19 | Vaccine Adverse Reaction | Vaccine Reaction | Kidney Failure, Chronic

Poland
Victory Nutrition International, Inc.

Recruiting

Efficacy Of "Prodovite®" In Athletic Performance (VMP35SPORT)

SPORTS NUTRITION

United States
Victory Nutrition International, Inc.

Recruiting

Clinical Study on Prodovite® VMP35 Supplement on Athletic Performance (VMP35Sport)

Athletic Performance

United States
The Immunobiological Technology Institute (Bio-Manguinhos)...
Rockefeller University

Recruiting

Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers

Drug-Related Side Effects and Adverse Reactions

Brazil
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell Carcinoma | Recurrent Lung Non-Small Cell Carcinoma

United States
GlaxoSmithKline

Completed

A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea

Neoplasms, Rectal

Korea, Republic of
Novo Nordisk A/S

Completed

Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients

Obesity

Mexico
VA Office of Research and Development
The George Institute

Completed

Prevention of Serious Adverse Events Following Angiography (PRESERVE)

Coronary Artery Disease | Acute Renal Failure | Kidney Disease

United States, Australia, New Zealand, Malaysia
Albert B. Sabin Vaccine Institute
ICON plc; Oklahoma Blood Institute

Completed

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Ebola Virus Disease | Marburg Virus Disease

United States
Tampere University Hospital

Active, not recruiting

Electronically Recorded National Early Warning Scores, Pain Scores and PONV Scores Among Hospitalized Patients

Prevention of In-hospital Adverse Events

Finland
Penumbra Inc.

Completed

Imaging Guided Patient Selection for Interventional Revascularization Therapy (START)

Acute Ischemic Stroke

United States
Atrial Fibrillation Network

Completed

Prospective Registration and Assessment of Serious Adverse Events Within the AFNET (AFNET A7)

Atrial Fibrillation | Assessment of Serious Advers Events | Thromboembolic and Bleeding Complications | Complications of Antiarrhythmic Drugs or Invasive Procedures | Assessment by a Critical Event Committee

Germany
Eisai Inc.
Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization

Completed

A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors (CAMELLIA-TIMI)

Obesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular Risk

United States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
GlaxoSmithKline

Completed

Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.

Asthma

Australia, New Zealand
French Society for Intensive Care

Completed

Analysis of Factors Related to Occurrence of Serious Adverse Events During Nursing in Intensive Care Units (NURSIE)

Critical Care | Nursing Caries

France, Switzerland, Belgium, Luxembourg
University Hospitals Cleveland Medical Center

Completed

Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa

Lymphatic Filariasis

Papua New Guinea
Centre Hospitalier Universitaire de Besancon
Etablissement Français du Sang

Completed

Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events (Pgp NACO)

Hemorrhage | Thromboembolism | Anticoagulants

France
University Hospital, Toulouse

Unknown

Hypersensitive Troponin Performance to Identify Syncope at Risk of Serious Adverse Events in the Short Term (TROPOCOPE)

Syncope

France
Janssen Research & Development, LLC

Completed

A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events

Aneurysm, Dissecting | Retinal Detachment | Achilles Tendon

United States
Universiteit Antwerpen
Belgian Federal Public Service, Food Chain Safety and Environment

Completed

Prevention of Serious Adverse Events in Acute Care Hospitals by Afferent Limb and Response Method Intervention - the ALARM Intervention Study. (ALARM)

Death, Sudden, Cardiac | Unexpected Hospital Mortality | Unplanned Intensive Care Unit Admission

Belgium
Hospices Civils de Lyon

Completed

Antibiotic-related Serious Adverse Events in Obese Patients Treated for Bone and Joint Infection

Obesity

France

Search clinical trials for: SAE serious adverse event

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations